Zentek (ZTEK) Cash from Financing Activities (2020 - 2026)
Zentek (ZTEK) posted Cash from Financing Activities of $297404.4 for Q1 2026, down 83.85% sequentially from $1.8 million in Q4 2025, and up 4800.03% YoY from $6069.4 in Q1 2025.
Zentek (ZTEK) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Zentek has reported Cash from Financing Activities for 7 years, with the latest figure at $297404.4 in Q1 2026.
- Quarterly Cash from Financing Activities rose 4800.03% year-over-year to $297404.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 77.95% YoY) and the FY2026 annual result came in at $3.3 million, up 82.64% from the prior year.
- Cash from Financing Activities declined to $297404.4 in Q1 2026 per ZTEK's latest filing, from $1.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $2.1 million in Q3 2024 and troughed at -$1.4 million in Q1 2023.
- A 5-year average of $243393.0 and a median of $27861.1 in 2023 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities tumbled 319.14% in 2024, then soared 4800.03% in 2026.
- Over 5 years, Cash from Financing Activities stood at $204388.7 in 2022, then plunged by 164.37% to -$131560.5 in 2023, then slipped by 6.69% to -$140360.8 in 2024, then jumped by 1412.14% to $1.8 million in 2025, then plunged by 83.85% to $297404.4 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $297404.4, $1.8 million, and -$16079.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Zentek | 63.90 Mn | 51.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297,404.35 |
| Mar 31, 2026 | 297,404.35 |
| Dec 31, 2025 | 1.84 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | -16,079.71 |
| Sep 30, 2025 | -16,079.71 |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 6,069.45 |
| Mar 31, 2025 | 6,069.45 |
| Dec 31, 2024 | -140,360.84 |
| Dec 31, 2024 | -140,360.84 |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | -108,807.61 |
| Jun 30, 2024 | -108,807.61 |
| Mar 31, 2024 | -71,479.60 |
| Mar 31, 2024 | -71,479.60 |
| Dec 31, 2023 | -131,560.45 |
| Dec 31, 2023 | -131,560.45 |